e-learning
resources
London 2016
Monday, 05.09.2016
Assessing lower airway inflammation with different tools
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Diagnostic value of FeNO in COPD and asthma - COPD overlap syndrome
Binu Krishnan (Trivandrum, India), Binu Krishnan, S. Priya
Source:
International Congress 2016 – Assessing lower airway inflammation with different tools
Session:
Assessing lower airway inflammation with different tools
Session type:
Poster Discussion
Number:
1844
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Binu Krishnan (Trivandrum, India), Binu Krishnan, S. Priya. Diagnostic value of FeNO in COPD and asthma - COPD overlap syndrome. Eur Respir J 2016; 48: Suppl. 60, 1844
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Characterization of airway inflammation in patients with asthma COPD overlap syndrome using FeNO levels
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
Using fractional exhaled nitric oxide level to differentiate asthma–COPD overlap syndrome from COPD
Source: International Congress 2018 – Airway disease: recent discoveries
Year: 2018
Is Fractional exhaled nitric oxide (FeNO) test reliable in the differentiation of chronic obstructive pulmonary disease (COPD) and ACOS (asthma-COPD overlap syndrome)?
Source: International Congress 2017 – Lung function testing in different patient categories
Year: 2017
The influence of asthma and COPD exacerbation on exhaled mitric oxide (FE
NO
)
Source: Eur Respir J 2004; 24: Suppl. 48, 409s
Year: 2004
The asthma–COPD overlap syndrome
Source: Eur Respir Monogr 2015; 69: 85-95
Year: 2015
Temporal stability of feno measurement in COPD
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
Exhaled NO (FeNO) levels in patients with exacerbation of COPD and/or bronchiectasis
Source: International Congress 2018 – Biomarkers for evaluating COPD
Year: 2018
Exhaled nitric oxide in diagnosis and management of respiratory diseases
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013
Two sites of airway obstruction identified by post-bronchodilation change of exhaled nitric oxide in COPD patients
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016
Concomitant use of fractional exhaled nitric oxide (FeNO) and asthma control test (ACT) as markers for predicting asthma exacerbation
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014
Differences between asthma–COPD overlap syndrome and adult-onset asthma
Source: Eur Respir J, 49 (5) 1602383; 10.1183/13993003.02383-2016
Year: 2017
Diagnosing asthma and prognostic significance of eNO
Source: Annual Congress 2005 - Are we ready for "inflammometry"? The role of eNO in asthma management
Year: 2005
Phenotypic characterization of asthma-COPD overlap syndrome: Comparison with asthma and COPD
Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases
Year: 2015
Combination of elevated exhaled nitric oxide and serum eosinophil cationic protein identifies asthma patients at risk for exacerbation
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015
Utility of FeNO in differentiating ACO and COPD
Source: International Congress 2019 – Airway physiology
Year: 2019
Characterization of allergic airway inflammation in patients with COPD using fractional exhaled nitric oxide levels
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
COPD and asthma overlap with bronchiectasis
Source: Eur Respir Monogr 2018; 81: 167-185
Year: 2018
Usefulness of fractional exhaled nitric oxide (FeNO) for early diagnosis of asthma in patients with nonspecific respiratory symptoms
Source: Annual Congress 2009 - From cough to sound analysis of breathing
Year: 2009
Exhaled nitric oxide (FeNO), sputum analysis and asthma control score in children with mild to moderate asthma
Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept